ASSOCIATIONS OF CLOZAPINE AVAILABLE INSTITUTION AND THE DIAGNOSIS OF SUBGROUPS ABOUT TREATMENT-RESISTANT SCHIZOPHRENIA OR NOT WITH A HIGHER RATE OF ANTIPSYCHOTIC MONOTHERAPY AND LOWER OTHER CONCOMITANT PSYCHOTROPICS IN OVERALL SCHIZOPHRENIA TREATMENT: A REALWORLD NATIONWIDE STUDY

Saved in:
Bibliographic Details
Title: ASSOCIATIONS OF CLOZAPINE AVAILABLE INSTITUTION AND THE DIAGNOSIS OF SUBGROUPS ABOUT TREATMENT-RESISTANT SCHIZOPHRENIA OR NOT WITH A HIGHER RATE OF ANTIPSYCHOTIC MONOTHERAPY AND LOWER OTHER CONCOMITANT PSYCHOTROPICS IN OVERALL SCHIZOPHRENIA TREATMENT: A REALWORLD NATIONWIDE STUDY
Authors: Shinichiro Ochi, Fumitoshi Kodaka, Naomi Hasegawa, Jun-Ichi Iga, Hiroko Kashiwagi, Hiroshi Komatsu, Hiromi Tagata, Takashi Tsuboi, Shusuke Numata, Hitoshi Iida, Shun Igarashi, Kazutaka Ohi, Kentaro Fukumoto, Hiroyuki Muraoka, Junya Matsumoto, Kenichiro Miura, Shu-Ichi Ueno, Koichiro Watanabe, Ken Inada, Ryota Hashimoto, et al
Source: The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2025 Supplement; Vol. 28.
Journal Info: Publisher: Oxford University Press / USA ISSN: 1461-1457
Database: MEDLINE Ultimate
Description
ISSN:1469-5111
DOI:10.1093/ijnp/pyae059.282